Rocket


Overview
Financials
News + Filings

 
 

Centrexion Therapeutics Corp Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues17.627.8
            Revenue growth-36.6% 
Cost of goods sold41.761.0
Gross profit-24.1-33.2
            Gross margin-136.7%-119.6%
Selling, general and administrative0.0-61.0
EBIT-24.1-33.2
            EBIT margin-136.7%-119.6%
Pre-tax income-25.1-37.7
Income taxes-0.40.0
            Tax rate1.8%0.0%
Net income0.00.0
            Net margin-0.1%-0.1%
 
Diluted EPS($19.91)($30.36)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy